DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.

DOMA Perpetual Capital Management LLC nominates three new directors to address Pacira's underperformance and lack of oversight

Mar. 12, 2026 at 12:20pm

Got story updates? Submit your updates here. ›

DOMA Perpetual Capital Management LLC, a 7.3% shareholder of Pacira BioSciences, Inc., has nominated three highly qualified director candidates to the company's board. DOMA believes these nominees are critical to address the board's lack of financial controls, sophistication and legal expertise, and to develop proper management oversight. The nominees possess significant experience in strategic capital allocation, risk management, healthcare, internal investigations, litigation, and due diligence.

Why it matters

Pacira's stock price has declined significantly over the past decade, with the company consistently missing earnings targets and lowering guidance. DOMA believes the board has failed in its oversight responsibilities, allowing management to make poor strategic decisions and receive excessive compensation despite the company's poor performance. Electing DOMA's nominees could help turn the company around and maximize value for all shareholders.

The details

DOMA is nominating Christopher Dennis, a visionary physician executive with experience in behavioral health and substance use disorders, Oliver Benton Curtis III, a former federal prosecutor and accomplished trial lawyer, and Eric de Armas, the CFO and CCO of DOMA Perpetual with extensive experience in corporate finance and risk management. DOMA believes these nominees can address the board's lack of financial and legal expertise, and provide proper oversight of the company's strategy and management.

  • DOMA announced its director nominations on March 12, 2026.

The players

DOMA Perpetual Capital Management LLC

A fundamentals-based, value-oriented investor that owns approximately 7.3% of Pacira BioSciences' outstanding shares.

Christopher Dennis

A visionary physician executive and board-certified psychiatrist with 25+ years of leadership across behavioral health, substance use disorders, and digital health.

Oliver Benton Curtis III

A former federal prosecutor and accomplished trial lawyer who currently advises on regulatory enforcement, internal investigations, and due diligence.

Eric de Armas

The CFO and CCO of DOMA Perpetual, with over two decades of experience in the financial industry and substantial knowledge of corporate finance, risk management and strategic capital allocation.

Pacira BioSciences, Inc.

A biopharmaceutical company focused on non-opioid pain management solutions.

Got photos? Submit your photos here. ›

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

This case highlights growing concerns in the community about repeat offenders released on bail, raising questions about bail reform, public safety on SF streets, and if any special laws to govern autonomous vehicles in residential and commercial areas.